Common Body of Knowledge

throatcopyΔιαχείριση

7 Νοε 2013 (πριν από 4 χρόνια και 1 μήνα)

82 εμφανίσεις

RESRUCTURING OF MSM/PHARMA MANAGEM
ENT and MSIS/IT PHARMA PROGRAMS

Murrae Bowden


Director MSM/Pharma Management



Dear MSM Pharma Management and IT Pharma Management student,

Over th
e

past
few months
, Carol Brown (Director IT/Pharma program) and I have
been engaged
in an initiative

to integrate the pharma content constituting the separate certificates for both
the
MSM/Pharma Managem
ent and MSIS/IT Pharma programs
. There were many similarities
between the
respective
concentration courses
stemming from th
e common body of knowledge
that connects the
functional business
and IT domains of the business
, and therefore redundancies
in content
.

By cross
-
listing the MSM and MSIS courses, we now can also offer both

on
-
campus

and online sections of the courses each

semester.

This letter describes the rationale for integrating the two
certificate programs

and the
changes to
be made to
cross
-
list

the courses
(
under
MGT and MIS course numbers) in the future.



All new

Pharmaceutical Management
and
IT
Pharma students will now begin the
program with a Trends and Issues course (MGT
686
/MIS 671).



If you are an
IT Pharma

student, you will continue to take the same four MIS courses
.



If you are a

new

Pharma Management

student, you will have three required cou
rses and
one pharma elective of your own choosing.



Beginning
in
Spring
2010
,
both IT Pharma and Pharma Management students will
receive the same certificate, with a new n
ame: Pharma
ceutical

Technology Management
Certificate.



A.

Rationale for Integrating
the Two Programs

The Pharma Value chain comprises all of the functional business elements from drug discovery
through commercialization
,

and includes critical supporting functions, such

as supply chain
logistics and
regulatory and compliance.


IT is an ena
bler at the strategic and operational levels
for all elements of the functional
p
harma value chain
. Hence there is

a strong synergy between
the business
functions comprising the

pharma value chain and the IT strategic/operational
platform
enabling

those
f
unctions
.

It leads

to a

common body of
knowledge encompassing
BOTH the business and IT domains that is required for optimal planning and executi
on of the
respective functions (Figure 1).






B.

The Common Body of Knowledge


Functional business managers not only need to know about the value chain and how the
functional elements interact, but also how the IT function can enable/support those functions.
Likewise the IT professional needs to know the functional elements of the va
lue chain to
establish the context for the applications that they are required to develop. The interface between
these two areas
(Figure 2)
represents the area of common knowledge between both disciplines.









Figure
2: Interface between Business Mgt. and IT Mgt.

Figure
1: Design Framework

From the
design
framework
,
we have identified
the following seven [
7
]

courses
which

encompass the integrated value chain and which lie in the interface between functional busine
ss
management and IT management

(Figure 2)
:



1.

Pharmaceutical Overview and Trends (MGT
686
/MIS 671)

The course will provide an overall look at IT in the pharmaceut
ical industry, its structure, and
trends and
the
issues
that

have driven it, are affecting it now, and are likely to change it in the
future. This course will focus on the business forces shaping the pharmaceutical industry. In
addition, this course will use management research on the integration of IT with the bus
iness.
The student will learn how to evaluate important business trends and how IT can be used to
support business success. Topics include a pharmaceutical industry overview, regulatory
compliance, new drug development, manufacturing and logistics, product

marketing, the role of
IT in the pharmaceutical industry, company strategies, e
-
pharma, and 21st century
pharmaceutical
-
market future trends.


2.

Drug Development in the Pharmaceutical Industry (MGT 681/MIS 672)


This course provides an overview of the drug
and biologics development process from discovery
through regulatory approval. Special attention is given to the roles, functions, and importance of
the various disciplines involved in the R&D process, their interactions with each other, and the
strategic m
anagement of these functions. Attention will also be given to key technologies,
including information technology, used throughout the R&D process. The economics of
pharmaceutical R&D, as well as trends in licensing, outsourcing, and partnerships will be
co
vered. The student will gain an understanding of R&D strategy and the relationship between
R&D and sales, marketing, and manufacturing.

3.

Marketing and Sales in the Pharmaceutical Industry (MGT 682/MIS 674


This course focuses on the organizational, manageme
nt, and technology issues related to the
sales and marketing function of the pharmaceutical industry as one of its principal boundary
-
spanning functions. This course will use extensive research and current literature on
pharmaceutical sales and marketing b
usiness approaches and technologies that drive or support
sales and marketing plans, as well as information and knowledge management considerations
that drive competitive distinctiveness. This course will also explore the real and potential
information and

knowledge linkages between the sales and marketing function and the
discovery, product development, and supply chain functions of the pharmaceutical industry.

4.

Pharmaceutical Industry Supply Chain Management (MGT
687
/MIS673)

This course focuses on the issu
es surrounding supply chain design, planning, and execution for
the pharmaceutical and biotech industries from drug discovery to delivery. This course will use
research on information systems, optimization, e
-
business, and decision
-
support technologies
and

lessons learned from their effective use in global supply chain management for
manufacturing and distribution in the process industries. Students will learn how to evaluate
global supply chain issues from the perspectives of various stakeholders in relati
onship to overall
organization and societal goals. They will further understand the different mechanisms for
collaboration and create a process for establishing and maintaining an effective global SCM
solution architecture. Topics include good manufacturin
g practice and regulations, advanced
planning and scheduling, global competition, mergers and acquisitions, innovation, new tools
and partnerships, effective global supply chain management, and qualifying for a global supply
chain manager position.

5.

IT Appl
ications in the Pharmaceutical Industry
(MGT
688
)



This course provides a comprehensive view of the strategic role of information and IT
applications in the context of the pharmaceutical and biotechnology industry. Examples of IT
applications for the
business functions (research and development, marketing and sales,
manufacturing, and logistics) will be examined in terms of their strategic advantages. The roles
of IT governance and an IT
-
business strategic planning process will be discussed, including
models to use for making IT investment decisions. Relevant IT management trends within the
industry (such as BPO and IT outsourcing) as well as the IT role in enabling healthcare industry
reforms (such as clinical information exchanges) will also be explor
ed.

6.

Regulation and Compliance in the Pharmaceutical Industry (MGT 684/PME 542/)


This course explores the U.S. and international regulatory environments that govern the
pharmaceutical and biotechnology industries with particular focus on the U.S. Food and
Drug
Administration, the European Agency for the Evaluation of Medical Products, and the Japanese
Ministry of Health, Labor, and Welfare. The essential components of Good Laboratory Practices,
Good Clinical Practices, and Good Manufacturing Practices regul
ations will be covered.
Students will develop an understanding of the formulation and execution of regulatory strategy
and key ethical issues in medical research. Where appropriate, case studies will be used to
illustrate the challenges and issues associat
ed with compliance, as well as the consequences of
non
-
compliance. Ethical issues and the potential consequences of ethical lapses will also be
explored. Current events will be used to illustrate key ethical principles and serve as a basis for
discussion.

7.

Introduction to Pharmaceutical Manufacturing (MGT 683/PME 530/)

Pharmaceutical manufacturing is vital to the success of the technical operations of a
pharmaceutical company. This course is approached from the need to balance company
economic considerations

with the regulatory compliance requirements of safety, effectiveness,
identity, strength, quality, and purity of the products manufactured for distribution and sale by
the company. Quality assurance and regulatory issues in pharmaceutical manufacturing.
O
verview of chemical and biotech process technology and equipment, dosage forms and
finishing systems, facility engineering and health, safety, and environment concepts. Regulatory
and legal overview.

C.

Certificate & Degree Structure

The
se

seven courses compr
ise
the concentration
core and

(for students in Pharma Management)
electives (designated by a
n

* in the figure below), from which students can tailor their
corresponding certificate. The certificate can subsequently be expanded to the corresponding MS
degr
ees as shown below:






D.

Changes in the MSM Pharma Management Program

The new Pharma Management certificate/concentration is related to the old structure
,
but a few
key changes have been made. Mgt 671 has been moved to the business core and has been
replaced in the certificate/concentration with Pharma Trends and Issues.
The
Pharma Logistics,
Marketing and Sales
course
has been replaced with Pharma Marketin
g & Sales. And the name of
the R&
D course

has been changed to Drug Development in the Pharmaceutical Industry. All four
courses comprising the certificate now have a pharma focus. As before, students take
three [3]

required courses and one elective whose c
hoice has been expanded to include four courses:
Supply Chain, Regulation & Compliance, IT Applications and Introduction to Manufacturing.

Changes have also been made to the core courses comprising the MS/Pharma Management
program as a result of the gene
ral restructure of the MSM program. The new core structure is as
follows:

Figure
3: Degree Structure


MSM Pharma Management Core Courses

MSIS IT Pharma Core Courses

MGT 609 Introduction to Project Management

MGT 609 Introduction to Project Management

MGT 600 Accounting for
Managers

MGT 623 Financial
Manage
ment

MGT 607 Managerial Economics

MGT 68
9

Organizational Behavior and Design

MGT 620 Statistical Models

MIS 710 Process Innovation & Management

MGT
689

Organizational Behavior and Design

MIS 730 Integrating IS technologies

MGT 671 Technology and Innovation Management

MIS 750 Managing IT Organizations

MGT 663 Discovering & Exploiting Entrepreneurial
Opportunities

MIS 760 IT Strategy

MGT
699

Strategic Management

Elective


In the ne
w Pharma Management construct, Mgt 680 (Organization
al

Behavior and Theory) and
Mgt 690

(Organizational Theory and Design)

have been combined into one course,

Mgt 68
9

(Organizational Behavior and
D
esign);

Mgt 679 (Management Information Systems) has bee
n
replaced with Mgt
699

(Strategic Management)
; Mgt 663 Discovering and Exploiting
Entrepreneurial Opportunities has been added to the core. The MSIS/IT pharma core remains
unchanged.

E.

Implications for Current Students

Students who have taken courses in accord with the old study plan may elect to stay with the
original study plan, or switch to the new study plan with appropriate substitution for courses
already taken.
Please note that the changes will not increase the nu
mber of courses that you
will need to take to complete your degree
, nor will they require you to change your existing
study plan which is grandfathered.

You are free to make changes though if you so wish.

F.

Conclusion

We believe the new structure captures t
he synergies across both programs. It greatly strengthens
the value proposition of the Pharma Management program, providing students with knowledge
in the core functional disciplines and expanded elective choice in specific areas of interest.
Students ca
n still leverage their respective MS degrees to the corresponding MBA degree at
Stevens.

Murrae Bowden

Director, MSM/Pharma Management

Email:
mbowden&stevens.edu

Phone:
201
-
216
-
8191